Power Training Post-stroke
Skeletal Muscle Plasticity As An Indicator of Functional Performance Post-Stroke
1 other identifier
interventional
56
1 country
1
Brief Summary
Hemiparesis, strictly defined as (muscular) weakness affecting one side of the body, is seen in three-quarters of individuals following stroke. Weakness in this population results from both neural and muscular factors which include, respectively, the ability to activate skeletal muscle as well as the force generating capacity of the muscle. The overall goal is to improve walking in persons post-stroke by training subjects with an intervention that specifically targets existing neural and muscular impairments, thereby facilitating locomotor recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 stroke
Started Oct 2013
Longer than P75 for phase_2 stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 22, 2013
CompletedFirst Posted
Study publicly available on registry
October 28, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedResults Posted
Study results publicly available
March 6, 2020
CompletedMarch 6, 2020
February 1, 2020
4 years
October 22, 2013
February 20, 2020
February 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait Speed
The speed the subject chooses to walk when instructed to walk at their "comfortable speed"
8 weeks
Secondary Outcomes (1)
Muscle Strength
8 weeks
Study Arms (1)
POWER
EXPERIMENTALIndividuals with chronic post-stroke hemiparesis will undergo training to improve muscle power generation for 24 sessions (3 times/week) that includes both resistive and task-specific elements. Session duration will be \~90 minutes/day (inclusive of rest intervals). Training will include five distinct resistance activities aimed at improving muscle power-- each previously reported to contribute to improved walking.
Interventions
Individuals with chronic post-stroke hemiparesis will undergo training to improve muscle power generation for 24 sessions (3 times/week) that includes both resistive and task-specific elements. Session duration will be \~90 minutes/day (inclusive of rest intervals). Training will include five distinct resistance activities aimed at improving muscle power-- each previously reported to contribute to improved walking
Eligibility Criteria
You may qualify if:
- age 50-70,
- stroke within the past 6 to 24 months,
- residual paresis in the lower extremity (Fugl-Meyer Lower Extremity motor score \<34),
- ability to walk without assistance and without an ankle foot orthotic (AFO) on the treadmill 30 seconds at speeds ranging from 0.3 - 0.8 m/s, and
- provision of informed consent.
- In addition, all subjects who meet criteria for the training portion must complete an exercise tolerance test and be cleared for participation by the study cardiologist.
You may not qualify if:
- Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking;
- rating on Modified Ashworth Scale 3 at the knee or ankle;
- limited lower extremity range of motion of the knee (passive flexion Range of Motion \[ROM\] \< 90); hip (inability to achieve neutral 0 hip extension); or ankle (inability to achieve 0 of active dorsiflexion);
- history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living (ADLs);
- History of chronic obstructive pulmonary disease (COPD) or oxygen dependence;
- Preexisting neurological disorders, dementia or previous stroke;
- History of major head trauma;
- Legal blindness or severe visual impairment;
- history of significant psychiatric illness
- Life expectancy \<1 yr.,
- Severe arthritis or other problems that limit passive ROM;
- post-stroke depression (PHQ-9 10),
- History of deep vein thrombosis (DVT) or pulmonary embolism within 6 months;
- Uncontrolled diabetes with recent diabetic coma, or frequent insulin reactions;
- Severe hypertension with systolic \>200 mmHg and diastolic \>110 mmHg at rest;
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, 29401-5799, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
None noted
Results Point of Contact
- Title
- Chris Gregory
- Organization
- Medical University of South Carolina
Study Officials
- PRINCIPAL INVESTIGATOR
Chris M Gregory, PhD
Ralph H. Johnson VA Medical Center, Charleston, SC
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2013
First Posted
October 28, 2013
Study Start
October 1, 2013
Primary Completion
September 29, 2017
Study Completion
May 31, 2019
Last Updated
March 6, 2020
Results First Posted
March 6, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share